Q&A: Dr Christina Yap talks about SPIRIT and CONSORT guidance
Dr Christina Yap and her team developed the SPIRIT and CONSORT guidance to assist researchers write papers on Phase I clinical trials.
Seagen reports positive data on Tukysa from Phase III breast cancer trial
Delpor on track with schizophrenia implant late-stage trials
Vesper Bio doses first patient in Phase I frontotemporal dementia trial
NeuroSense’s trial of ALS drug meets primary and secondary endpoints
Merck’s multiple sclerosis therapy trials fail to meet primary goals
Analysis
View More
Themes
View MoreBerlin Cures announces expansion of long Covid drug study
The company aims to publish the first results from the trial next year.
More themes
Premium Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover premium insights powered by our properietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Junshi publishes positive Phase III results for Covid-19 pill VV116
University of Queensland’s vaccine shows virus-neutralising effect in trial
AIM ImmunoTech concludes dosing in Phase II post-Covid drug trial
Why COP28 is “the most important COP” since the Paris Agreement